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Abstract 
In previous studies, we developed serum-free, bovine pituitary extract (BPE)-free culture conditions for the 
growth of normal and neoplastic rat mammary epithelial cells. The present studies were aimed at determin- 
ing if these culture methods could be used to study the influence of specific growth factors on the proliferative 
potential of normal human mammary epithelial (HME) cells and cells derived from human breast cancer 
(HBC) specimens. Our results indicate that normal HME cells in primary culture express stringent require- 
ments for insulin (IN), epidermal growth factor (EGF), and cholera toxin (CT). Of these factors, EGF is 
most important, with essentially no proliferation taking place in the absence of this factor. By contrast, when 
cells are grown in serum-free primary culture in the presence of a full complement of growth factors and then 
subcultured, growth in secondary culture is not influenced by the removal of individual growth factors. 
Growth in secondary culture in the absence of EGF is mediated by autocrine factors secreted by the cells. 
However, there is no evidence for autocrine activity that mediates growth in the absence of IN in secondary 
cultures. Primary culture of HBC cells in serum-free, BPE-free medium revealed two patterns of growth 
factor requirements. One set of HBC cells expressed identical requirements for IN and EGF in primary 
culture as normal cells. Likewise, these cells grew in secondary culture in the absence of either factor. The 
second set of tumors expressed independence of IN for growth in primary culture. These cells grew to 
confluence in primary culture in the absence of IN and could be subcultured in this medium. All tumor cells 
examined expressed a requirement for EGF for primary culture growth, whereas none of the HBC cells 
examined expressed a significant CT requirement. In many cases, growth in the absence of CT exceeded that 
observed in its presence. Thus, our culture system allows analysis of the growth factor requirements of HME 
and HBC cells in primary culture. Our results indicate significant differences between HME and HBC cells 
in this regard. However, the results of secondary culture experiments indicate that the growth factor milieu 
from which cells are taken can have a profound effect on the requirements for growth factors in culture. 
Introduction 
There are now many culture systems based on 
media that support extended growth of human 
mammary epithelial cells from normal and neo- 
plastic tissues. The first such medium was devel- 
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oped by Stampfer etal. [1]. This medium consists of 
a combination of serum and growth factor-supple- 
mented fresh medium and conditioned medium 
obtained from various human cancer cell lines. In 
this culture medium, normal tissue and human 
breast cancer derived mammary epithelial cells can 
be grown in mass culture for one to three passages, 
and addition of a fibroblast feeder layer growth 
allows growth at clonal densities [2]. 
Culture systems that support growth of normal 
HME cells have now been significantly refined. 
Growth of these cells over extended periods has 
been achieved in a growth factor-supplemented 
serum-free medium containing BPE. For growth 
over a few passages, the BPE can be replaced by 
prolactin (M) and prostagladin E-l, allowing 
growth of HEM cells in a defined medium [3]. 
Media designed for growth of HBC cells have also 
been developed. Peterson and van Deurs [4] re- 
ported growth of HBC cells in primary culture in a 
growth factor-supplemented serum-free medium. 
More recently, long term growth and serial passage 
of HBC cells has been reported by Band and Sager 
[5] using a growth factor-supplemented medium 
containing both BPE and serum. The emphasis of 
much of the work performed with the culture sys- 
tems described above has been on developing con- 
ditions suitable for long-term growth of human 
mammary cells and, whenever possible, establish- 
ing cell lines. Consequently, there has been rela- 
tively little emphasis placed on the role of individu- 
al growth factors on the proliferative potential of 
the cells in primary and secondary cultures in the 
absence of the undefined factors present in serum 
and BPE. 
In previous work, we developed culture systems 
that support extended growth of normal and ne- 
oplastic rat mammary epithelial cells under serum- 
free, BPE-free, conditions [6, 7]. These systems 
were used to compare directly the proliferative 
potential and growth factor requirements of nor- 
mal and neoplastic rat mammary cells [8]. The 
present studies were designed to determine if the 
culture methods used to study the proliferative po- 
tential of normal and neoplastic rat mammary epi- 
thelial cells could be ,~_sed for studies of HME cell 
growth and to compar~ the growth factor require- 
ments of normal tissue and breast cancer-derived 
human mammary cells in primary and secondary 
culture. 
Material and methods 
Preparation of cells for culture 
Normal HME cells were obtained by enzymatic 
dissociation of normal tissues obtained from reduc- 
tion mammoplasties or from biopsy specimens. Pri- 
mary breast cancer specimens were obtained from 
The University of Michigan Breast Care Center. 
Enzymatic dissociation of both normal and breast 
cancer tissue was performed essentially as de- 
scribed previously for rat mammary tissues [9]. 
Briefly, tissues were minced with scalpels and in- 
cubated overnight in type III collagenase (200 
units/ml, Worthington Biochemicals, Freehold, 
N J) in Medium 199 in a shaking water bath at 37 ° C. 
The cells were collected by centrifugation, washed 
in fresh Medium 199, and incubated in 0.05% Pro- 
nase (Calbiochem, LaJolla, CA) in Medium 199 at 
37 ° C. Following the pronase incubation, the cells 
were pipetted gently to break up large clumps of 
cells and then washed three times in fresh Medium 
199. The number of cells in the suspension was 
determined by counting isolated nuclei with a 
Coulter counter as described previously [6]. Epi- 
thelial aggregates were either seeded directly into 
culture or were frozen for future use. Cells were 
frozen in Medium 199 containing 20% FBS and 5% 
DMSO and freezing was accomplished using a 
step-freezer. 
Tissue culture conditions 
HME and HBC cells were plated at 2 x 105 or 5 × 
105 cells per 60 mm culture dish. The plates were 
coated with a type I collagen film (Vitrogen 100, 
Collagen Corp, Palo Alto, CA) and rinsed with 
Hank's balanced salt solution just prior to use. The 
serum-containing medium consisted of Ham's F-12 
(Hazelton Biologicals, Lenexa, KS) supplemented 
with ethanolamine (5 aM) ,  N-2-hydroxyethylpip- 
erazine-2-ethane sulfonic acid (HEPES, 10 mM), 
IN (5/xg/ml), hydrocortisone (ltxg/ml), EGF 
(10ng/ml), CT (100ng/ml), M (5/xg/ml), proges- 
terone (P, 100ng/ml), 2% fetal bovine serum 
(FBS), gentamycin (5/xg/ml), and fungizone 
(0.5 txg/ml). In the serum-free medium, the FBS 
was replaced with transferrin (5/xg/ml), bovine se- 
rum albumin (lmg/ml), sodium selenite (50ng/ 
ml), and triiodothyronine (10nM). Cells were 
maintained in a humidified atmosphere of 90% air 
and 10% CO2 and were fed three times per week. 
Cell growth assays 
To measure the proliferative potential of HME and 
HBC cells in various media in primary culture, cells 
were seeded into 60 mm dishes and 24 hours later 
the number of attached cells per dish was deter- 
mined. The cells were grown for 10 to 12 days with 
three to four medium changes, and the mean num- 
ber of cells per dish was determined for each group. 
Cell counts were performed by isolating nuclei di- 
rectly from monolayers and counting with a Coul- 
ter counter as done previously [9]. For experiments 
performed in secondary culture, cells were seeded 
into primary culture and grown for 12 days in the 
fully growth factor-supplemented serum-free me- 
dium. The cells were then sub-cultured and seeded 
at 105 cells per 60 mm culture dish in growth factor- 
free medium supplemented with 2% FBS (to allow 
cell attachment) overnight. The cells were then 
switched to different serum-free media in which 
individual growth factors were deleted and grown 
for an additional 10 days. To measure the influence 
of the EGF-receptor-antibody EGFR-425 on 
HME cell growth, cells were grown in primary 
culture in fully growth factor-supplemented serum- 
free medium and then switched in secondary cul- 
ture to EGF-free medium as described above. The 
cells were grown in EGF-free medium in the pres- 
ence or absence of EGFR-425. 
Conditioned medium was collected from HME 
cell cultures by growing the cells in secondary cul- 
ture in the absence of a single factor. When these 
secondary cultures became confluent, the cells 
were re-fed with fresh medium, incubated for an 
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additional 48 hours, and the media collected. To 
examine mitogenic activity in conditioned medium 
obtained from HME cell cultures, the normal hu- 
man mammary epithelial cell line MCF-10 were 
used as indicator cells [10]. MCF-10 cells were 
kindly provided by Dr. Herbert Soule of the Michi- 
gan Cancer Foundation. MCF-10 cells were seeded 
at 105 cells per 35 mm culture dish and grown in 
serum-free medium supplemented with IN, HC, 
and EGF, or in medium devoid of IN or EGF and 
containing conditioned medium obtained from 
HME cells that were grown in secondary culture in 
the absence of the same factor. 
Immunocytochemistry 
To examine cytokeratin expression in HME and 
HBC cells, cells were grown in primary culture in 
the fully growth factor-supplemented serum-free 
medium on collagen-coated coverslips (Lux, Flow 
Laboratories, McLean VA). The cells were fixed 
and stored in cold ethanol and stained by indirect 
immunofluorescence. 
Materials 
The EGFR-425 antibody was kindly provided by 
Dr. Donald Buchsbaum of The University of Mi- 
chigan, and the Tab-1 antibody was kindly provid- 
ed by Dr. Beatrice Langton of Triton Bioscience, 
Alameda, CA. IN, HC, EGF, M, P, triiodothyro- 
nine, sodium selenite, ethanolamine, HEPES, and 
transferrin were obtained from Sigma Chemical 
Co. (St. Louis, MO), CT was from Schwartz-Mann 
(Spring Valley, NY), Vitrogen was from the Colla- 
gen Corporation (Palo Alto, CA), and Ham's F-12 
was from Hazelton Biologicals (Lenexa, KS). Lux 
coverslips were obtained from Flow Laboratories 
(McLean, VA). 
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Fig. 1. Primary culture of HME cells obtained from a reduction 
mammoplasty in 2% serum-containing or serum-free medium in 
the presence of a full complement of growth factors or in the 
absence of individual factors. The cells were grown for 12 days 
and the number of ceils per dish was determined by counting 
isolated nuclei with a Coulter counter. The attached fraction 
(AF) indicates the number of attached cells per dish 24 hours 
after plating• The legends for the individual bars indicate the 
growth factors present in each medium; I = insulin, H = hydro- 
cortisone, E = epidermal growth factor, C = cholera toxin. In 
all figures, error bars indicate the range. 
Results 
Growth factor requirements of  H M E  cells in 
primary culture 
To examine the influence of individual growth fac- 
tors on the proliferative potential  of normal H M E  
cells in pr imary culture, epithelial aggregates were 
obtained by enzymatic dissociation of one reduc- 
tion mammoplas ty  specimen and two biopsy speci- 
mens that consisted of histologically normal  mam-  
mary tissue. The cells were plated at low density on 
collagen-coated 60 m m  culture dishes and allowed 
to attach overnight in HEPES-buffered  H a m ' s  
F-12 medium supplemented with ethanolamine,  
hydrocortisone, and 2% FBS (plating medium).  
The next day, attached cells were washed and 
switched to serum-free medium supplemented with 
various growth factor combinations. Also at this 
time, the number  of attached cells in triplicate 
plates was determined.  The cells were grown for 12 
days with four medium changes, and the number  of 
cells per dish was determined by counting isolated 
nuclei. The results of a pr imary culture deletion 
experiment  per formed with cells from the reduc- 
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Fig. 2. Influence of progesterone (P) and prolactin (M) on HME 
cell growth in primary culture in the absence of either insulin 
(IN) or EGF. The experiment was performed as described in 
Fig. 1. - IN or - EGF indicate growth in the absence of the 
growth factor. 
Over  the 12 day culture period, growth in the fully 
growth factor-supplemented serum-free medium 
was equivalent to that obtained in a similar medium 
that also contained 2% FBS. Also, deletion of M 
and P from the medium did not result in any de- 
crease in primary culture growth. By contrast, de- 
letion of CT resulted in an approximately 50% 
reduction in cell growth, and deletion of either IN 
or E G F  dramatically reduced the proliferative po- 
tential of the ceils. Thus, for these H M E  cells, as 
for rat mammary  epithelial cells [7] and other cul- 
tured epithelial cell types [11-14], there is a syn- 
ergistic interaction between IN and E G F  in stim- 
ulating cell growth. 
Although addition of M and P to the complete 
culture medium did not result in enhanced cell 
proliferation, these hormones  did enhance growth 
when tested in the absence of either IN or EGF.  
The data in Fig. 2 show that growth in the absence 
of IN or E G F  was greater in the presence of M and 
P than in their absence. Thus, under sub-optimal 
culture conditions, mammogenic  hormones  do 
have detectable effects on H M E  proliferation. 
Primary culture deletion experiments were also 
per formed with two biopsy samples that were 
shown to be histologically normal,  and the results 
of these experiments are given in Figs 3A and B. 
These results confirm the results of experiments 
with reduction mammoplasty-der ived cells and in- 
dicate that both IN and E G F  are required for H M E  
cell growth. However ,  the cells f rom these two 
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Fig. 3. Primary culture growth of HME cells obtained from two 
different biopsy specimens that were shown histologically to 
consist of normal mammary epithelium. Cells were grown in 
serum-free medium in the presence of IN, HC, EGF, and CT 
(IHEC) or in the absence of one factor. Cells were grown for 12 
days and then counted as described above. 
samples exhibited much greater dependence on CT 
than did the reduction mammoplasty cells. This 
finding is consistent with results reported previous- 
ly that indicate sample to sample variability with 
regard to CT requirements for in vitro growth [15]. 
The above results indicate that HME cells re- 
spond dramatically to the presence or absence of 
individual growth factors in primary culture. To 
determine if the cells respond similarly in second- 
ary cultures, HME cells were plated as described 
above and grown for 12 days in serum-free medium 
in the presence of a full complement of factors. The 
cells were then sub-cultured and grown for seven 
days in medium devoid of specific factors. The data 
in Fig. 4 show that the cells exhibited little or no 
sensitivity to growth factor withdrawal in the first 
passage. The cells grew as well in the absence as in 
the presence of CT or EGF. Growth in the absence 
of IN was reduced in comparison to the other 
groups, but the fold-increase in cell number was 
much greater in secondary culture than in primary 
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Fig. 4. Secondary culture of reduction mammoplasty derived 
HME cells. Cells were grown for 12 days in primary culture in 
fully growth factor-supplemented serum-free medium. The cells 
were subcultured and grown for an additional 12 days in serum- 
free medium in the absence of individual growth factors. The 
legends for individual bars indicate the growth factors present in 
each medium. 
been obtained in several experiments employing 
both normal and HBC-derived cells. 
To determine if autocrine growth factor synthe- 
sis could account for the lack of growth factor re- 
quirements in secondary culture, experiments were 
performed using the newly developed human 
mammary epithelial cell line MCF-10 as indicator 
cells, These Cells can be serially propagated in our 
serum-free medium and have an absolute require- 
ment for both IN and EGF. For these experiments, 
HME cells were grown for 12 days in primary cul- 
ture in fully growth factor-supplemented medium, 
subcultured, and grown for an additional seven to 
ten days in medium devoid of either EGF or IN. 
When these secondary cultures became nearly con- 
fluent (after three medium changes), the cells were 
re-fed with fresh medium and incubated for an 
additional 48 hours, and these conditioned media 
were collected. The conditioned media obtained in 
this way were tested for their ability to support 
growth of MCF-10 cells in the absence of either IN 
or EGF (Fig. 5). The results from this experiment 
show that MCF-10 cells are exquisitely sensitive to 
IN and EGF, and that conditioned media obtained 
from secondary cultures contain potent EGF-like 
activity but no detectable IN-like bioactivity. To 
determine if the activity present in the conditioned 
medium from minus-EGF secondary cultures was 
responsible for the growth of the cells under these 
conditions, experiments were performed using the 
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Fig. 5. The influence of conditioned medium, obtained from 
secondary cultures of HME cells grown in the absence of either 
IN or EGF, on growth of MCF-10 cells. Conditioned medium 
was obtained from secondary HME ceils as described in Meth- 
ods. MCF-10 cells were grown in serum-flee medium in the 
presence of IN, HC, and EGF (IHE) or in the absence of either 
IN or EGF. Cells grown in the absence of either IN or EGF were 
tested for their response to HME-derived conditioned medium 
obtained from secondary cultures grown in the absence of the 
same factor. 
neutralizing EGF-receptor antibody EGFR-425 
[16]. HME cells were grown in primary culture in 
fully supplemented medium, and then grown in 
secondary culture in the absence of EGF and in the 
presence or absence of EGFR-425. The results in- 
dicate that growth in the secondary cultures in the 
absence of EGF is abolished by the EGF-receptor 
antibody (Fig. 6). 
It has been reported that culture of HME cells 
results in the synthesis of TGF-alpha by the cells 
[17]. Therefore, we attempted to measure TGF- 
alpha by radioimmunoassay in conditioned medi- 
um obtained from secondary cultures of HME 
cells. Thus far we have not detected TGF-alpha 
immunoreactive material in conditioned medium 
that contains EGF-like bioactivity. Furthermore, 
growth of HME cells in secondary culture in the 
absence of EGF was not inhibited by incubation 
with the TGF-alpha neutralizing antibody (Table 
1), even at concentrations as high as 100/xg/ml 
(data not shown). Thus, the identity of the EGF- 
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Fig. 6. Influence of the EGF-receptor antibody EGFR-425 on 
growth of secondary HME cell cultures in the absence of EGF. 
HME cells were grown in primary culture in fully growth factor- 
supplemented serum-free medium, subcultured, and grown in 
secondary culture in the absence of EGF and in the presence or 
absence of 1/xg/ml EGFR-425. 
Growth factor requirements of HBC-derived cells in 
primary culture 
Since primary culture deletion experiments are in- 
formative with regard to the growth factor require- 
ments of HME cells, similar experiments were per- 
formed with cells derived by enzymatic dissociation 
of HBC specimens. Thus far we have obtained 15 
HBC samples and have successfully cultured cells 
from 12 of them. Of these 12, primary culture dele- 
tion experiments have been performed on 8 sam- 
ples and interpretable results have been obtained 
from 7 of the 8 experiments. Thus far, two patterns 
of growth factor requirements have been detected. 
The data obtained from the cells designated SUM-13 
are representative of one pattern, in which the 
requirements for IN and EGF are indistinguishable 
from those of normal cells but which show better 
growth in the absence than in the presence of CT 
(Fig. 7). Also presented in Fig. 7 are the results of 
secondary culture deletion experiments that show 
the same loss of growth factor sensitivity for HBC 
cells in the first passage as for normal tissue-de- 
rived HME cells. 
The data obtained from SUM-18 are representa- 
tive of the second pattern of primary culture growth 
observed thus far. These cells expressed significant 
growth potential in primary culture in the absence 
of IN as well as in the absence of CT (Fig. 8). Cells 
derived from these tumors grew to confluence in 
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Fig. 7. Primary culture (A) and secondary culture (B) of HBC 
cells designated SUM-13 in serum-containing and serum-free 
medium in the presence or absence of individual growth factors. 
The experiments were performed as described in Figs 1 and 4. 
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Fig. 8. Primary culture of HBC cells designated SUM-18 in 
serum-containing or serum-free medium in the presence or ab- 
sence of individual growth factors. 
of CT, and 5 of 7 specimens grew in the absence of 
IN. Although the number of tumors examined thus 
far is small, the five tumors that yielded positive 
growth in the absence of IN are from patients with 
low or negative estrogen receptor (ER) and pro- 
gesterone receptor (PR) levels, and were taken 
from patients that had locally advanced and/or 
metastatic disease. 
subcultured. This level of growth in IN-free medi- 
um is many fold greater than anything that we have 
observed with normal tissue-derived cells. 
The results obtained with the seven primary tu- 
mors analysed to date are summarized in Table 1. It 
is noteworthy that 5 of 5 specimens tested ex- 
pressed excellent growth potential in the absence 
Cytokeratin expression in proliferating HME and 
HBC-derived cultures 
The culture conditions used in these experiments 
were originally developed for growth of normal 
and neoplastic rat mammary epithelial cells and to 
minimize growth of stromal cells [9]. The HME and 
Table 1. Characteristics of human breast cancers for which primary culture deletion data are available 
Tumor designation Histo/path Dx a Node status ER b PR b Growth - IN c Growth - CT ~ 
SUM-12 IC, LCIS medullary CA neg 12 neg - + 
SUM-13 Invasive duct. CA neg 875 658 - + 
SUM-4 Invasive duct. CA neg neg neg + + 
SUM-7 Invasive duct. CA 11/13 d 50 neg + NT e 
SUM-16 Invasive duct. CA 15/15 d neg neg + NT e 
SUM-18 Invasive duct. CA neg 12 147 + + 
SUM-23 Invasive duct. CA neg 12 neg + + 
a IC, intraductal carcinoma; LCIS, lobular carcinoma in situ; Invasive duct. CA, invasive ductal carcinoma. 
b Estrogen and progesterone receptor levels in fmols per mg protein. 
c Ability of the cells to grow to confluence in primary culture in the absence of either IN or CT. 
d Number  of nodes positive for breast cancer/number of nodes examined. 
NT, not tested. 
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HBC cells that grew under these culture conditions 
exhibited a typical epithelial cell morphology. Fur- 
thermore, the majority of HME and HBC cells 
reacted positively with a broad spectrum antiker- 
atin antiserum, and less than 5% of the cells ex- 
pressed vimentin detectable by immunofluores- 
cence. 
In summary, the results indicate that our serum- 
free primary culture system can be used to analyze 
the growth factor requirements of normal and pri- 
mary breast cancer-derived human mammary epi- 
thelial cells. Our results also indicate that the re- 
quirements of HME cells for growth factors are 
dramatically influenced by the culture environ- 
ment, such that first passage cells express markedly 
different growth factor requirements than do pri- 
mary cells. Furthermore, cells derived from some 
primary HBC express altered requirements for IN 
and CT for growth in primary culture. 
Discussion 
The results of these experiments indicate that the 
growth factor requirements of normal and human 
breast cancer-derived mammary epithelial cells can 
be compared in serum-free, BPE-free primary cul- 
ture. The culture medium used for these experi- 
ments was originally developed for our studies of 
growth of normal and neoplastic rat mamary epi- 
thelial cells. Although there are many similarities 
between our medium and those used by other 
groups for growth of human mammary epithelial 
cells [3, 5], there are significant differences. First, 
we use Ham's F-12 as the basal medium, which in 
our hands is superior to other formulations, in- 
cluding 50 : 50 mix of F-12 and DMEM. Second, 
primary and secondary culture growth factor ex- 
periments are performed in the absence of either 
serum or BPE. Indeed, BPE does not improve 
growth of HME or HBC cells in primary culture in 
our serum-free medium. Thus, our culture medium 
most closely resembles the medium developed by 
Peterson and van Deurs [4]. Our serum-free medi- 
um does contain BSA which is not completely de- 
fined. The BSA is greater than 99% pure; how- 
ever, previous studies have shown that fatty acids 
associated with the BSA are important to the 
growth potential of the cells [6]. Thus, BSA in the 
growth medium is important for maintenance of 
the proper osmotic pressure and as a source of fatty 
acids. The latter function is physiological, in that 
fatty acids are toxic in free form and are presented 
to cells in vivo associated with BSA. There is no 
evidence that BSA is a source of undefined growth 
factors, and neither rat nor human mammary epi- 
thelial cells express any growth in BSA-containing 
medium that is not supplemented with exogenous 
growth factors. 
In primary culture, HME cells exhibit sensitivity 
to individual growth factors. These cells, like many 
other cultured epithelial cell types, grow rapidly in 
the presence of IN, HC, EGF, and a cAMP agonist 
such as CT. Deletion of IN, EGF, or CT results in 
dramatic loss of growth potential. When the same 
cells are first grown in the presence of a full comple- 
ment of factors and then tested for responsiveness 
to deletion of individual factors, dramatically dif- 
ferent results are obtained. HME cells (and HBC 
cells) grow as well in the absence as in the presence 
of either EGF or CT in secondary culture. In addi- 
tion, growth in secondary culture in the absence of 
IN is much greater than that seen in minus-IN 
primary cultures. The ability of HME cells to grow 
in secondary culture in the absence of EGF is medi- 
ated by autocrine factors secreted into the medium. 
By contrast, there is no IN-like activity in condi- 
tioned medium obtained from cultures grown in 
the absence of IN. The results obtained in these 
experiments are consistent with those obtained in 
other laboratories that indicate up-regulation of 
growth factors, growth factor receptors, and proto- 
oncogenes upon initiation of primary culture of 
HME cells [17-19]. 
Primary culture experiments performed with 
cells obtained from primary breast cancers re- 
vealed two patterns of growth factor response. 
First, all tumors examined thus far grew well in 
primary culture in the absence of CT. In many cases 
growth in the absence of CT is greater than that 
observed in its presence. Second, 5 of 7 tumors 
examined have expressed good growth in primary 
culture in the absence of IN. These cells come to 
confluence in primary culture in minus-IN medium 
and can be serially p ropaga ted  in the absence of  
this factor.  These  results represent  clear differ- 
ences be tween  the response  of  H M E  and H B C  
cells to growth  factors  in p r imary  culture.  How-  
ever,  the results must  be in terpre ted  in light of  the 
data  ob ta ined  in the secondary  culture exper iments  
pe r fo rmed  with H M E  and H B C  cells. The  ability 
to grow in p r imary  culture in the absence of  individ- 
ual growth  factors  m a y  reflect genetic  changes  im- 
por tan t  to the neoplast ic  potent ia l  of  the H B C  
cells. Al ternat ively ,  this pheno type  m a y  be a re- 
flection o f  the env i ronment  f rom which the H B C  
cells were  obta ined.  That  is, the milieu of  the pri- 
mary  t u m o r  may  be similar to that  of  the pr imary  
culture env i ronment  where  growth  factors are pre-  
sent. Thus,  placing cells in p r imary  culture f rom 
such an env i ronment  m a y  be akin to starting sec- 
onda ry  cultures of  normal  cells following pr imary  
culture in the presence  of  growth  factors. Distin- 
guishing be tween  these two possibilities will pro-  
vide a significant insight into the factors  that  drive 
prol i fera t ion of  H B C  cells in vivo. 
Immunocy tochem i c a l  analysis of  cells grown 
f rom normal  and neoplast ic  tissues indicates that  
they are epithelial cells. Howeve r ,  it is much  more  
difficult to state unequivocal ly  that  cells grown 
f rom breast  cancer  specimens are indeed  neoplast ic  
cells. In an a t tempt  to minimize the presence  of  
normal  m a m m a r y  elements  in H B C  samples,  we 
have worked  with samples taken  f rom patients en- 
tering a clinical pro tocol  for  locally advanced  dis- 
ease. These  patients do not  receive mastec tomies  
but  ra ther  receive open  biopsies for  staging purpos-  
es. Thus,  our  l abora tory  receives t umor  pieces 
f rom the central  areas of  large lesions that  are 
sampled on the basis of  their gross neoplast ic  ap- 
pearance .  Since these biopsies are for  staging pur-  
poses,  they are given careful  h is topathologic  eval- 
uat ion.  There fore ,  the source of  the cells used in 
these exper iments  and their al tered growth  factor  
requi rements  in serum-free  culture suggest that  
they are indeed  h u m a n  breast  cancer  cells. How-  
ever,  fur ther  work  will be required  to demons t ra te  
this unequivocal ly .  
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